07/07/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2025 5:39 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/30/2025 5:14 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/23/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025 1:03 PM | ALTERITY THERAPEUTICS LTD (Subject) Alterity Therapeutics (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SCHEDULE 13G/A | |
05/05/2025 5:17 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2025 8:59 AM | ALTERITY THERAPEUTICS LTD (Subject) Alterity Therapeutics (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for ATHE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
04/30/2025 7:05 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2025 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2025 8:47 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/07/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/07/2025 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/07/2025 7:02 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025 7:31 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 5:13 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2025 6:32 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2025 5:50 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025 6:59 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025 6:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 5:08 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2025 5:56 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 7:13 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 6:59 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/10/2025 6:25 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/10/2025 6:17 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025 7:01 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2025 5:33 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 7:02 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad) Right now, we’re witnessing a monumental shift in the world. Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. |
01/28/2025 5:33 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2025 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2025 7:02 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025 5:35 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025 7:05 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/31/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2024 6:35 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024 5:58 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024 6:10 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2024 6:14 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/19/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 5:27 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2024 7:00 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024 7:48 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024 8:15 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2024 5:26 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 5:20 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:30 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:32 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:33 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 3:40 PM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
09/23/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 5:03 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024 5:07 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 6:06 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2024 5:23 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/24/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/19/2024 5:31 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/19/2024 5:22 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2024 7:00 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024 5:51 AM | ALTERITY THERAPEUTICS LTD (Filer) Alterity Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |